Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Anticancer Research|August 28, 2024
The Predictive Value of Different Glasgow Prognostic Scores and the LabBM Score for Patients With Recurrent GlioblastomaDirk Rades, Oksana Zemskova, Jan Leppert, et al.
In Vivo (Athens, Greece)|April 30, 2024
The Role of Radiotherapy for Meningeal Melanocytomas - A 20 Year UpdateDirk Rades, Oksana Zemskova, Jan Gliemroth, et al.
Anticancer Research|June 26, 2024
Prognostic Factors for Progression-free Survival and Overall Survival After Recurrence of GlioblastomaOksana Zemskova, Nathan Y Yu, Jan Leppert, et al.
Anticancer Research|June 23, 2023
Hypo-fractionated Radiotherapy (HF-RT) <i>Versus</i> Conventionally Fractionated Radiotherapy (CF-RT) for GlioblastomaOksana Zemskova, Eugene Pedachenko, Nathan Y Yu, et al.
Cancer Diagnosis & Prognosis|July 4, 2024
Prognostic Role of Platelet-to-Lymphocyte and Neutrophil-to-Lymphocyte Ratios in Patients Irradiated for Glioblastoma MultiformeOksana Zemskova, Nathan Y Yu, Anastassia Löser, et al.
In Vivo (Athens, Greece)|June 27, 2024
Evaluation of Five Prognostic Scores in Patients Receiving Chemoradiation for Primary Glioblastoma MultiformeOksana Zemskova, Nathan Y Yu, Anastassia Löser, et al.
Anticancer Research|May 29, 2023
Identification of Patients With Glioblastoma Who May Benefit from Hypofractionated RadiotherapyOksana Zemskova, Nathan Y Yu, Peter Trillenberg, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 26, 2025
From fractionation to financials: economic and clinical implications of hypofractionation in German outpatient radiotherapy practiceAnastassia Löser, Monika Huth, Akvile Juskeviciute, et al.
Pageof 2